KOSDAQIT & Software340810

Secern AI

₩3,000▼ 12.15%2026-11-18 close
Market Cap
₩42.6B
Turnover
₩5B
Volume
1.6M
Shares out.
14.2M
PER
—
PBR
4.8×
EPS
-₩779
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Flat revenue, widening losses and funding pressure at Secern AI

Secern AI's revenue has stayed near KRW 14 billion since 2022 while operating losses widened every year, and convertible bond issuance and sales through 2026 have made its funding structure the central issue.

  1. 1

    Revenue fell from KRW 16.8 billion in 2022 to KRW 14 billion in 2025, while operating losses widened from KRW 6.34 billion to KRW 11.3 billion over the same period. The company has posted losses for four consecutive years from 2022 through 2025.

  2. 2

    Operating losses have continued for five consecutive quarters from the third quarter of 2025 through the third quarter of 2026, and the parent-attributable net loss over the last four quarters totals KRW 10.8 billion.

  3. 3

    A media analysis of year-end 2025 data reported cash and equivalents fell 76.7% to KRW 2.47 billion, and operating cash flow was KRW -5.99 billion in 2025.

  4. 4

    Public-sector AI contracts and the first commercial robotics deal arrived in the second half of 2026, alongside a government healthcare R&D selection. Whether these translate into a revenue recovery is a question for the next periodic report.

02

Business structure

Secern AI is a Korean AI video-recognition solutions company that listed on KOSDAQ in May 2023.

According to the corporate information platform Butler, its revenue mix in the second quarter of 2026 was SI business 43%, AI face recognition systems 25%, AI object recognition solutions 11%, AI face authentication solutions 7% and other 8%.

Expanded supply of face recognition systems to public facilities such as airports, government offices and casinos was cited as a driver of revenue growth in the first half of 2026.

Its product lineup includes SEEU ON, a zero-trust screen information protection solution, SEEU DOC, a document AI engine, and IntraGenX, a closed-network AI coding assistant launched in March 2026.

Its robotics business sits in a subsidiary spun off in 2025, which is commercializing agricultural logistics robots and a multipurpose robotic gripper.

In September 2026 the company won a KRW 2.45 billion Air Force closed-network AI project, according to the independent research firm CMIR, which published its analysis on November 11, 2026. The company also launched its SEEU Health remote-care platform in Japan in October 2026.

Competition overlaps with large IT services players such as NAVER, Samsung SDS and LG CNS as well as face-recognition and video-analytics specialists, and the scale gap is wide.

Government projects and public-sector orders make up a large share of business, so revenue depends heavily on the timing of individual projects.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩3B-₩1.8B−60.2%
2025Q4₩8.7B-₩2.5B−28.6%
2026Q1₩3.3B-₩2.8B−84.0%
2026Q2₩2.5B-₩2.8B−111.7%
2026Q3₩2.9B-₩2.9B−99.1%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩16.8B-₩6.3B-₩8.3B−37.7%−203.9%813.5%
2023₩14.1B-₩9.8B-₩9.6B−69.3%−46.7%106.4%
2024₩14.4B-₩10.4B-₩10.7B−72.3%−105.6%188.9%
2025₩14B-₩11.3B-₩15.2B−80.7%−104.0%128.5%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Annual revenue fell from KRW 16.8 billion in 2022 to KRW 14.1 billion in 2023, a 16.1% decline year on year, recovered to KRW 14.4 billion in 2024 (up 2.5%), and dropped to KRW 14 billion in 2025 (down 3.3%). 2022 was the largest year in the period and 2025 the smallest.

Over the same period operating losses widened from KRW 6.34 billion in 2022 to KRW 9.77 billion in 2023, KRW 10.4 billion in 2024 and KRW 11.3 billion in 2025, and the operating margin deteriorated from -37.7% to -80.7%. Revenue stayed flat in the KRW 14 billion range while costs rose, so the loss grew.

The parent-attributable net loss widened from KRW 8.3 billion in 2022 to KRW 9.63 billion, KRW 10.7 billion and KRW 15.2 billion in 2025. The net loss including non-controlling interests was KRW 15.3 billion in 2025 and should be read as a separate figure.

The debt-to-equity ratio fell from 813.5% in 2022 to 106.4% in 2023, then rose to 188.9% in 2024 and 128.5% in 2025. At year-end 2025 total equity was KRW 15.4 billion, of which KRW 14.6 billion belonged to parent shareholders, and total liabilities were KRW 19.8 billion.

Operating cash flow was negative in all four years, at KRW -828 million in 2022, KRW -6.4 billion in 2023, KRW -8.32 billion in 2024 and KRW -5.99 billion in 2025.

Quarterly revenue rose to KRW 8.71 billion in the fourth quarter of 2025, up 186.4% from the prior quarter, then fell to KRW 3.28 billion in the first quarter of 2026, KRW 2.5 billion in the second and KRW 2.94 billion in the third, which returned it to the KRW 3 billion range.

The composition of the fourth-quarter 2025 revenue spike cannot be separated from the disclosed figures alone.

Operating losses were KRW 1.83 billion in the third quarter of 2025, KRW 2.49 billion in the fourth, KRW 2.76 billion in the first quarter of 2026, KRW 2.79 billion in the second and KRW 2.91 billion in the third, five consecutive quarters of losses with the loss widening each quarter.

The parent-attributable net loss also expanded from KRW 1.65 billion in the fourth quarter of 2025 to KRW 3.35 billion in the third quarter of 2026. The size of any one-off items should be checked in the notes to the 2026 annual report.

05

Industry analysis

Secern AI operates in a market where government manufacturing AI policy and defense and public-sector AI procurement are expanding at the same time.

The M.AX Alliance, run by the industry ministry, targets more than KRW 100 trillion in added value from manufacturing AI transformation by 2030, and the ministry is directing KRW 70 billion of its 2026 AI budget to five alliance-led projects.

Secern AI said on November 13, 2026 that it received registration approval in three divisions: industrial complex AX, defense and factory.

The industrial-complex division covers intelligent video control using existing CCTV, the defense division covers vision-AI and robotics-based picking automation and quality inspection, and the factory division covers worker safety management and missing-part detection.

In healthcare, the company is developing a smartphone-camera inhalation coaching solution aimed at a respiratory treatment market it describes as worth KRW 100 trillion, and it was selected as a joint R&D institution in a 2026 government health technology project with a three-year term and government funding of about KRW 825 million.

Large IT players such as NAVER, Samsung SDS, LG CNS and Hyundai AutoEver hold scale advantages in public and financial SI markets. Secern AI points to its own GPU infrastructure and on-premises licensing as differentiators, but no verified market-share figure is available.

In face recognition it competes with established security and access-control vendors. Policy demand is rising, but how quickly it converts into annual revenue has not yet shown up in reported results.

06

Outlook

The company has laid out three commercialization paths. First, expanding IntraGenX and its vision-AI products in public and defense markets.

A September 2026 Air Force closed-network project gave it a first defense reference, and the company said IntraGenX is in talks with two large distribution companies and that it plans a SaaS version alongside its on-premises licensing. Second, commercializing its robotics business.

It signed a first commercial supply contract with a regional agricultural cooperative's packing facility in October 2026 and said it plans to extend supply to other regional packing facilities nationwide, including apple and citrus producers, after the Seongju melon case.

A robotics partner with a nationwide sales network joined the field sales effort after a memorandum of understanding signed in September 2026. Third, expanding overseas and into healthcare.

The company launched its AI remote-healthcare platform in Japan in October 2026, and its respiratory platform plans to enter through clinical research and inhaler evaluation tools before moving into SaMD certification and B2B hospital markets.

It aims to later secure FDA and CE approvals to enter North America and Europe and license to global pharmaceutical companies.

The company was also selected in June 2026 as a joint R&D institution for an AI-based smart public bus system with total project costs of KRW 3.57 billion, and it is developing the on-device LLM agent and vision-AI recognition.

The revenue timing and amounts for these projects and contracts have not been disclosed, and no official earnings guidance was found. In the next periodic report, the key benchmarks are how 2026 annual revenue compares with KRW 14 billion in 2025 and whether the KRW 11.3 billion operating loss narrows.

07

Valuation

PER
—
PBR
4.8×
ROE
-107.7%
EPS
-₩779
BPS
₩712
Dividend per share
₩0

Secern AI has posted losses attributable to parent shareholders for the last four quarters, so its PER cannot be calculated. Earnings-based metrics do little to explain its valuation, and price-to-book is the main reference point.

The share price sits in a range with a large premium over net asset value, and market capitalization is several times the equity attributable to parent shareholders. The company pays no meaningful dividend, so dividends offer little support to the share price.

Among same-sector listed peers, NAVER and Samsung SDS trade on earnings-based multiples, so a multiple comparison with a loss-making company is not meaningful. Trading volume on November 16, 2026 was reported at 12.4 times its 20-day average.

The benchmark for reading the multiple will be how operating losses and total equity change in the 2026 annual report.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Expanding public and defense AI orders

CMIR, an independent research firm, highlighted in a November 11, 2026 report that Secern AI won a KRW 2.45 billion Air Force closed-network AI project in September 2026. The project gave IntraGenX its first defense reference.

The company said it is in talks with two large distribution companies on adopting the product. Whether public-sector wins broaden the revenue base is the core of the bull case.

First commercial physical-AI robotics contract

Its robotics subsidiary signed a first commercial supply contract with a regional agricultural cooperative's packing facility in October 2026 for agricultural logistics automation. The company said this differs from government projects because the customer bears operating costs directly.

A memorandum of understanding on robotics automation was signed with a Hanwha-group robotics partner in September 2026, referred to here as a robotics partner. The company plans to expand supply to regional packing facilities nationwide.

Alignment with government AI policy

Secern AI said on November 13, 2026 that it received registration approval in three divisions of the M.AX Alliance run by the industry ministry. The ministry is directing KRW 70 billion of its 2026 AI budget to five alliance-led projects.

Starting with the 2027 budget, it has said it will prioritize projects proposed by the alliance. Whether the policy benefit turns into actual project awards is the open question.

09

Bear factors

Widening losses and flat revenue

Revenue fell from KRW 16.8 billion in 2022 to KRW 14 billion in 2025, while operating losses grew from KRW 6.34 billion to KRW 11.3 billion over the same span. The third-quarter 2026 operating loss of KRW 2.91 billion is larger than the KRW 1.83 billion in the third quarter of 2025.

Growing reliance on external funding

In April 2026 the company sold a KRW 2.5 billion face-value tranche of convertible bonds it had reacquired to raise operating funds. A media analysis reported year-end 2025 cash and equivalents fell 76.7% to KRW 2.47 billion. Operating cash flow was KRW -5.99 billion in 2025. The largest single-tranche potential dilution was reported at 20.98%.

Receivables burden and share dilution

Receivables were reported at 60.2% of 2025 revenue, which suggests sales are not converting quickly into cash. An analysis by a Korean research outlet counted more than ten rights offerings, convertible bond issues and sales of reacquired bonds in 2026.

Repeated financing of this kind adds to cumulative dilution for existing shareholders. How many conversion shares are actually issued will show up in future disclosures.

10

Risk factors

Liquidity and funding

Operating cash flow was negative in each of the last four years, and a media analysis reported year-end 2025 cash fell to KRW 2.47 billion. The company relies on convertible bond issuance and sales, so conversion shares increase the share count as they reach the market. Delays in raising funds could limit investment capacity.

Reliance on government projects and order volatility

Project sizes vary widely, from about KRW 825 million in government funding for the respiratory project to KRW 3.57 billion in total costs for the bus project and KRW 2.45 billion for the defense network project. Because individual awards drive revenue, quarterly results can swing sharply with project timing.

The move to KRW 8.71 billion in the fourth quarter of 2025 and back to around KRW 3 billion afterward illustrates this.

Commercialization stage of new technologies

The respiratory platform is planned in stages: clinical research, SaMD certification, then FDA and CE approvals. Overseas approvals and global licensing remain plans rather than achievements. If these timelines slip, the revenue contribution will also be delayed. Progress will be judged from future periodic reports and interim project results.

11

What to watch next

  1. December 31, 2026 (fourth-quarter close)

    Check year-end cash and equivalents and the pace of convertible bond conversions. This is the baseline for judging whether funding pressure is easing.

  2. Around February 2027 (typical timing)

    In the 2026 full-year preliminary results, compare revenue and operating loss with KRW 14 billion and KRW 11.3 billion in 2025.

  3. By March 31, 2027

    The statutory filing deadline for the 2026 annual report. It is the next periodic benchmark for operating margin, debt ratio and operating cash flow.

  4. After December 2026 (timing not set)

    Track progress on the Air Force defense network project and whether IntraGenX adoption deals with defense or distribution customers are signed. The speed at which backlog converts into revenue is the key issue.

12

Overall view

Secern AI's revenue has stayed near KRW 14 billion since 2022 while operating losses widened to KRW 11.3 billion in 2025, and losses have continued for five consecutive quarters from the third quarter of 2025 through the third quarter of 2026.

On funding, operating cash flow was negative for four straight years, and a media analysis reported that year-end 2025 cash fell, with convertible bond issuance and sales recurring.

On the other side, 2026 brought a defense-network AI award, the first commercial robotics supply contract, registration approval in three M.AX Alliance divisions, and a government healthcare project selection, which broaden the base of orders and contracts.

The bull case rests on whether public-sector and defense demand and physical-AI commercialization can grow the revenue base. The bear case rests on a structure in which losses and funding pressure grow together while revenue stays flat.

Both will be tested by how revenue, operating loss and cash flow change in the 2026 annual report. With no PER currently calculable, valuation interpretation is tied to whether earnings recover. This report is for information only and sets out facts to verify.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. thevc.kr
  2. comp.wisereport.co.kr
  3. dailyan.com
  4. comp.fnguide.com
  5. sisamagazine.co.kr
  6. view.asiae.co.kr
  7. butler.works
  8. comp.fnguide.com
  9. news.nate.com
  10. thedailypost.kr
  11. newspim.com
  12. newspim.com
  13. news.nate.com
  14. news.nate.com
  15. news.nate.com
  16. newspim.com
  17. rapportian.com
  18. m.news.nate.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis